Allison Bratzel
Stock Analyst at Piper Sandler
(4.92)
# 195
Out of 4,361 analysts
232
Total ratings
63.9%
Success rate
42.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Allison Bratzel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $84 → $82 | $53.32 | +53.79% | 6 | May 21, 2026 | |
| HUMA Humacyte | Maintained: Hold | $1 | $1.39 | -28.06% | 8 | May 14, 2026 | |
| RIGL Rigel Pharmaceuticals | Maintained: Hold | $40 | $30.02 | +33.24% | 9 | May 13, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,075 | $802.17 | +34.01% | 33 | May 11, 2026 | |
| ALXO ALX Oncology Holdings | Maintained: Buy | $4 | $1.78 | +124.72% | 6 | May 11, 2026 | |
| CDXS Codexis | Maintained: Buy | $9 | $2.69 | +234.57% | 11 | May 8, 2026 | |
| ENGN enGene Therapeutics | Downgraded: Hold | $26 → $4 | $1.74 | +129.89% | 4 | May 8, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $68 | $21.78 | +212.21% | 6 | May 7, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $52 | $32.76 | +58.73% | 8 | May 7, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $165 | $72.50 | +127.59% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $42.96 | +14.06% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $5.52 | +189.86% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $92.24 | +19.25% | 11 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $72.97 | +37.04% | 13 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.9364 | +327.17% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $30 | $9.24 | +224.68% | 5 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.28 | +180.37% | 5 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $4 | $8.87 | -54.90% | 8 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $10.13 | +196.15% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $56 | $28.66 | +95.39% | 5 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $58 | $44.68 | +29.81% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.5 | $0.0034 | +14,605.88% | 5 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $6.13 | +177.32% | 5 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $28.25 | n/a | 6 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $6.58 | n/a | 6 | Mar 14, 2024 |
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $84 → $82
Current: $53.32
Upside: +53.79%
Humacyte
May 14, 2026
Maintained: Hold
Price Target: $1
Current: $1.39
Upside: -28.06%
Rigel Pharmaceuticals
May 13, 2026
Maintained: Hold
Price Target: $40
Current: $30.02
Upside: +33.24%
argenx SE
May 11, 2026
Maintained: Buy
Price Target: $1,075
Current: $802.17
Upside: +34.01%
ALX Oncology Holdings
May 11, 2026
Maintained: Buy
Price Target: $4
Current: $1.78
Upside: +124.72%
Codexis
May 8, 2026
Maintained: Buy
Price Target: $9
Current: $2.69
Upside: +234.57%
enGene Therapeutics
May 8, 2026
Downgraded: Hold
Price Target: $26 → $4
Current: $1.74
Upside: +129.89%
Ultragenyx Pharmaceutical
May 7, 2026
Maintained: Buy
Price Target: $68
Current: $21.78
Upside: +212.21%
Cogent Biosciences
May 7, 2026
Maintained: Buy
Price Target: $52
Current: $32.76
Upside: +58.73%
ABIVAX Société Anonyme
May 6, 2026
Maintained: Buy
Price Target: $165
Current: $72.50
Upside: +127.59%
May 5, 2026
Maintained: Buy
Price Target: $49
Current: $42.96
Upside: +14.06%
May 1, 2026
Maintained: Buy
Price Target: $16
Current: $5.52
Upside: +189.86%
Apr 24, 2026
Maintained: Buy
Price Target: $110
Current: $92.24
Upside: +19.25%
Apr 24, 2026
Maintained: Buy
Price Target: $100
Current: $72.97
Upside: +37.04%
Apr 24, 2026
Maintained: Buy
Price Target: $4
Current: $0.9364
Upside: +327.17%
Apr 22, 2026
Maintained: Buy
Price Target: $26 → $30
Current: $9.24
Upside: +224.68%
Apr 21, 2026
Maintained: Buy
Price Target: $12
Current: $4.28
Upside: +180.37%
Apr 10, 2026
Downgraded: Hold
Price Target: $14 → $4
Current: $8.87
Upside: -54.90%
Mar 24, 2026
Maintained: Buy
Price Target: $30
Current: $10.13
Upside: +196.15%
Mar 20, 2026
Maintained: Buy
Price Target: $42 → $56
Current: $28.66
Upside: +95.39%
Mar 4, 2026
Maintained: Buy
Price Target: $51 → $58
Current: $44.68
Upside: +29.81%
Jan 23, 2026
Downgraded: Hold
Price Target: $3 → $0.5
Current: $0.0034
Upside: +14,605.88%
Jul 28, 2025
Maintained: Buy
Price Target: $20 → $17
Current: $6.13
Upside: +177.32%
Jul 18, 2024
Maintained: Buy
Price Target: $22
Current: $28.25
Upside: n/a
Mar 14, 2024
Upgraded: Buy
Price Target: $8 → $20
Current: $6.58
Upside: n/a